^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Ultra-Sensitive Signatera™ Genome MRD Test

    Company:
    Natera
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    7ms
    Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting (Natera Press Release)
    " Natera, Inc...today announced that data from more than 25 Signatera studies will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 30 – June 3, 2025 in Chicago, IL."
    Clinical data
    |
    Ultra-Sensitive Signatera™ Genome MRD Test